Avani Satish Dholakia

Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

Joseph M. Herman, Daniel T. Chang, Karyn A. Goodman et al. · Cancer · 2014 · 526 citations · Full text

Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer

Aaron T. Wild, Joseph M. Herman, Avani Satish Dholakia et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 226 citations · Full text

Radiation Medicine, Surgical Oncology, Pancreatic Cancer +10

The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience

Shalini Moningi, Avani Satish Dholakia, Siva P. Raman et al. · Annals of Surgical Oncology · 2015 · 158 citations · Full text

Adaptive Radiotherapy, Pancreatic Cancer, Radiation Therapy +7

Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor–vessel relationships

Avani Satish Dholakia, Amy Hacker‐Prietz, Aaron T. Wild et al. · Journal of Radiation Oncology · 2013 · 78 citations · Full text

Neoadjuvant Chemoradiation, Tumor–vessel Relationships, Surgical Oncology +10

Baseline Metabolic Tumor Volume and Total Lesion Glycolysis Are Associated With Survival Outcomes in Patients With Locally Advanced Pancreatic Cancer Receiving Stereotactic Body Radiation Therapy

Avani Satish Dholakia, Muhammad Chaudhry, Jeffrey P. Leal et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 77 citations · Full text

Survival Outcomes, Oncology, Pancreatic Cancer +8